Daily SPF : Non-negotiable
Tirzepatide is the active ingredient in Mounjaro and Zepbound, medications that are dual-action GLP-1/GIP antagonists that have been shown to help people lose an average of 25% of their body weight.* A Zealthy provider will review your healthcare assessment & prescribe Mounjaro, Zepbound, or compounded tirzepatide, if appropriate
Doses of 125-250 mg after meals and at bedtime are standard for adults, up to 500 mg per day
Though he acknowledges that there are risks inherent with injecting drugs from suspect sources, Alvarez argues that the alternative stopping his use of anti-obesity medication, regaining weight, and watching his blood sugar climb back up is the greater danger
Jerry and the team in Sarver, PA can build and monitor yours
The GLP-1 component offsets the blood sugar concern while the glucagon component drives metabolic rate higher